To hear about similar clinical trials, please enter your email below
Trial Title:
Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors
NCT ID:
NCT06082648
Condition:
Rectal Neoplasms
Conditions: Official terms:
Rectal Neoplasms
Conditions: Keywords:
Ultra-low rectal tumors
Intersphincteric Resection
transcranial magnetic stimulation
fMRI
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Device
Intervention name:
Transcranial magnetic stimulation
Description:
The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator (
MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum
stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla.Stimulation
group: Intermittentpulse transcranial magnetic stimulation (iTBS) will be performed with
: the cluster consists of 3 pulses, the intra-cluster frequency is 50Hz, the intercluster
frequency is 5Hz, the interval is 8.2s for every stimulus. There are 20 cycles and a
total of 600 pulses. Each intervention time is 3min11s, and the stimulation intensity is
set as 80% resting state motion threshold. The intervention will be performed once a day
for 2 weeks.
Arm group label:
Post-ileostomy-closure Stimultion Group
Arm group label:
Pre-ileostomy-closure Stimultion Group
Intervention type:
Device
Intervention name:
Sham Transcranial magnetic stimulationt
Description:
The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator (
MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum
stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla. Patients on
the Sham stimulation group will be interfered with the stimulation coil perpendicular to
the skull, so that they will hear the sound of machine without having therapeutic
effects. The parameters will be the same as those in the stimulation group.
Arm group label:
Sham Stimultion Group
Summary:
To investigate the effects of intersphincteric resection (ISR) of ultra-low rectal tumor
on the brain-rectoanal function of patients, and to precisely localize the cerebral
functional regulatory regions for intervention targets of anorectal remodeling. Utilizing
transcranial magnetic stimulation(TMS) technology to explore the functional remodeling of
the "new" anorectal muscle groups and provide a theoretical basis for more research on
the rehabilitation and mechanism of fecal incontinence.
Detailed description:
This study is a Single-center Phase II, Open, Three-Arm clinical trial. We prospectively
enroll patients who undergo ISR for ultra-low rectal tumor in the department of General
Surgery, Huashan Hospital, Fudan University. Patients with ileostomy closure are randomly
divided into two groups (TMS group and false stimulation group), and healthy volunteers
were recruited. The differences of task-state fMRI between healthy volunteers, and ISR
patients (both preoperative and postoperative) are compared, combined with rectal
function scores (Wexner score, LARS score) and quality of life scale (EORTC QLQ-C30,
EORTC QLQ-CR38). Proctoanal manometry are used to find the precise location of the
proctoanal motor function area in the cerebral cortex, and to evaluate the effect and
value of TMS on postoperative anorectal motor function remodeling in patients with ISR.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Primary ultra-low rectal tumor patient who is received intersphincteric resection
and preventive ileostomy was performed.
- Patient who is willing to participate in the study, and voluntarily sign informed
consent.
Exclusion Criteria:
- Anastomotic leakage or other serious complications occur after surgery.
- Advanced tumor, tumor recurrence or metastasis.
- Patients with contraindications of fMRI scanning, such as history of metal implants
in the body, claustrophobia, etc.
- Patients with contraindications for TMS treatment, such as intracranial metal
implants, epilepsy history, heart disease with unstable heart function, retinal
detachment, etc.
- Combined with organic brain disease and drug abuse history.
- Combined with other mental diseases.
- Pregnant or lactating women.
Gender:
All
Minimum age:
18 Years
Maximum age:
75 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Huashan Hospital Affiliated to Fudan University
Address:
City:
Shanghai
Zip:
200040
Country:
China
Status:
Recruiting
Contact:
Last name:
Jianbin Xiang, doctor
Phone:
86-21-52887040
Email:
68875417@qq.com
Contact backup:
Last name:
Minwei Zhou, doctor
Phone:
86-21-52887040
Email:
zmwf1@126.com
Investigator:
Last name:
Jianbin Xiang, doctor
Email:
Principal Investigator
Start date:
June 1, 2023
Completion date:
October 30, 2026
Lead sponsor:
Agency:
Huashan Hospital
Agency class:
Other
Source:
Huashan Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06082648